MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis

BACKGROUND: The roles of microRNA (miR)-32 and miR-548a in non-small cell lung cancer (NSCLC) have been studied. But their influences on NSCLC cells to cisplatin (DDP) resistance remain elusive. This study estimated the mechanisms of miR-32 and miR-548a in NSCLC cells to DDP. METHODS: Differentially...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jian, Li, Xiaoxi, Cai, Cunwei, Hong, Chengyu, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039019/
https://www.ncbi.nlm.nih.gov/pubmed/33854371
http://dx.doi.org/10.2147/CMAR.S295003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039019/
https://www.ncbi.nlm.nih.gov/pubmed/33854371
http://dx.doi.org/10.2147/CMAR.S295003

Ejemplares similares